Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 82

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 82
---
 Viswanadhan are each within the aforementioned five-year phase-in period and as a result are not yet required to meet the stock ownership guidelines.

Compensation Committee Report

The compensation & people committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with our management. Based on this review and discussion, the compensation & people committee recommended to our board of directors that the Compensation Discussion and Analysis be included in this proxy statement.

This report of the compensation & people committee is not “soliciting material,” shall not be deemed “filed” with the SEC and shall not be incorporated by reference by any general statement incorporating by reference this proxy statement into any filing under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent that we specifically incorporate this information by reference, and shall not otherwise be deemed filed under such acts.

The foregoing report has been furnished by the compensation & people committee.

Respectfully submitted,

The Compensation & People Committee of the Board of Directors

Cynthia Smith (chair)

Kaye Foster

Catherine Owen**

<div align='center'>62</div>

Summary Compensation Table The following table shows information regarding the compensation of our NEOs during the fiscal years ended December 31, 2024, 2023 and 2022.

| Name and Principal Position                           |     | Year |      |    |     | Salary ($) |         |     |   Bonus 
     ($) |         |     |     Stock 
    Awards 
    ($)(1) |           |     |    Option 
    Awards 
    ($)(1) |           |     |     Non-equity 
 Incentive Plan 
   Compensation 
         ($)(2) |         |     |    All Other 
 Compensation 
       ($)(3) |        |     |  Total ($) |           |
| Brian Goff                                            |     |      | 2024 |    |     |            | 822,198 |     |         |       — |     |           | 1,742,580 |     |           | 3,480,506 |     |                | 719,423 |     |              | 11,653 |     |            | 6,776,359 |
| Chief Executive Officer                               |     |      | 2023 |    |     |            | 798,250 |     |         |       — |     |